Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
30,151,475
-
Share change
-
-295,943
-
Total reported value
-
$2,271,836,092
-
Put/Call ratio
-
14%
-
Price per share
-
$75.36
-
Number of holders
-
159
-
Value change
-
-$40,738,025
-
Number of buys
-
76
-
Number of sells
-
100
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q3 2015
As of 30 Sep 2015,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,151,475 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, VANGUARD GROUP INC, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, Grantham, Mayo, Van Otterloo & Co. LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, and Capital International Investors.
This page lists
159
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.